Sen, H. Nida

Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery

Cukras, C., Wiley, H. E., Jeffrey, B. G., Sen, H. N., Turriff, A., Zeng, Y., Vijayasarathy, C., Marangoni, D., Ziccardi, L., Kjellstrom, S., et al. (2018) · Molecular Therapy

Retinal Development and DisordersVirus-based gene therapy research

Cited by 268

Hypomethylation of the IL17RC Promoter Associates with Age-Related Macular Degeneration

Wei, L., Liu, B., Tuo, J., Shen, D., Chen, P., Li, Z., Liu, X., Ni, J., Dagur, P., Sen, H. N., et al. (2012) · Cell Reports

Retinal Diseases and TreatmentsEpigenetics and DNA Methylation

Cited by 167

Complement Component C5a Promotes Expression of IL-22 and IL-17 from Human T Cells and Its Implication in Age-Related Macular Degeneration

Liu, B., Wei, L., Meyerle, C., Tuo, J., Sen, H. N., Li, Z., Chakrabarty, S., Agron, E., Chan, C.-C., Klein, M. L., et al. (2011) · Journal of Translational Medicine

Complement system in diseasesRetinal Diseases and Treatments

Cited by 164

Immune function in X-linked retinoschisis subjects in an AAV8-RS1 phase I/IIa gene therapy trial

Mishra, A., Vijayasarathy, C., Cukras, C. A., Wiley, H. E., Sen, H. N., Zeng, Y., Wei, L. L., & Sieving, P. A. (2021) · Molecular Therapy

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 38

Gender differences in Behçet’s disease associated uveitis

Ucar-Comlekoglu, D., Fox, A., & Sen, H. N. (2014) · Journal of Ophthalmology

Ocular Diseases and Behçet’s SyndromeSarcoidosis and Beryllium Toxicity Research

Cited by 37

Antidrug antibodies to tumor necrosis factor α inhibitors in patients with noninfectious uveitis

Bellur, S., McHarg, M., Kongwattananon, W., Vitale, S., Sen, H. N., & Kodati, S. (2023) · JAMA Ophthalmology

Ocular Diseases and Behçet’s SyndromeInflammatory Bowel Disease

Cited by 34